Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Therapy”

393 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 393 results

Early research (Phase 1)Study completedNCT03685331
What this trial is testing

HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerAdvanced Breast Cancer+2 more
Abramson Cancer Center at Penn Medicine 9
Not applicableStudy completedNCT01302652
What this trial is testing

Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment

Who this might be right for
Acromegaly
Massachusetts General Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06760637
What this trial is testing

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Who this might be right for
Breast Cancer
Pfizer 1,035
Not applicableUnknownNCT04529356
What this trial is testing

The TMS Treatment for Postoperative Headache in GH Tumor

Who this might be right for
HeadachePituitary TumorAcromegaly
Huashan Hospital 200
Large-scale testing (Phase 3)Study completedNCT00943995
What this trial is testing

Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis

Who this might be right for
Kidney Failure, ChronicRenal Dialysis
Nationwide Children's Hospital 3
Not applicableStudy completedNCT05399329
What this trial is testing

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Who this might be right for
Breast Cancer
Pfizer 693
Post-approval studies (Phase 4)UnknownNCT06448195
What this trial is testing

Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery

Who this might be right for
Growth Hormone Treatment
Shanghai Zhongshan Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT04263298
What this trial is testing

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Herui Yao 210
Not applicableStudy completedNCT01543867
What this trial is testing

Safety and Efficacy of Long-term Somatropin Treatment in Children

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenFoetal Growth Problem+5 more
Novo Nordisk A/S 5,442
Not applicableStudy completedNCT04498481
What this trial is testing

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Who this might be right for
Breast Cancer
Pfizer 1
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT06247995
What this trial is testing

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 20
Early research (Phase 1)UnknownNCT00473187
What this trial is testing

Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets

Who this might be right for
Hypophosphatemic RicketsGrowth DisordersSomatropin Therapy
University of Rostock
Testing effectiveness (Phase 2)Ended earlyNCT03519178
What this trial is testing

PF-06873600 in People With Cancer

Who this might be right for
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
Pfizer 155
Testing effectiveness (Phase 2)Study completedNCT06379659
What this trial is testing

Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer

Who this might be right for
Thin EndometriumInfertility FemaleInfertility
Isfahan University of Medical Sciences 54
Not applicableStudy completedNCT00561769
What this trial is testing

Luteal Phase Commencing of Growth Hormone

Who this might be right for
Infertility
Gulhane School of Medicine 61
Not applicableWithdrawnNCT06113952
What this trial is testing

Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Pfizer
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05796440
What this trial is testing

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

Who this might be right for
Growth Hormone Deficiency
Lumos Pharma 60
Early research (Phase 1)Ended earlyNCT00803179
What this trial is testing

Growth Hormone Therapy for Wasting in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Massachusetts, Worcester 5
Large-scale testing (Phase 3)Study completedNCT04970654
What this trial is testing

A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.

Who this might be right for
Growth Hormone Deficiency in Children
Novo Nordisk A/S 110
Load More Results